> Per Jay Stallworth:
>> Is there something unique about this particular strain that makes
[quoted text clipped - 25 lines]
> facilities are substantially below what is actually needed and our surge
> capacity is nil.
All good points, particularly #3. The return on vaccine manufacturing
doesn't justify doing it especially given the liability it exposes the
manufacturer to.
HMc
"(PeteCresswell)" <x@y.Invalid> wrote in
> Per Jay Stallworth:
>> Is there something unique about this particular strain that makes
[quoted text clipped - 5 lines]
> transmisability (is that even a word..?.-) the exact strain upon which
> to base a vaccine is not available.
Isn't half a loaf better than none?
> 2) Flu vaccines have traditionally been manufactured by inoculating
> fertilized chicken eggs, letting the stuff grow for awhile on the
> chick embryo, and then harvesting the contents which is refined into
> vaccine. H5N1, however, is so lethal that it kills the chick embryo
> too soon - making the amount of vaccine per egg much less or zero.
Aren't the attenuated strains less lethal?
> 3) Vaccines are not money makers for the manufacturers. Money
> losers, in fact much of the time. So far, our government has not
> seen fit to exercise any of it's power to remedy this situation.
> Consequently, vaccine production facilities are substantially below
> what is actually needed and our surge capacity is nil.
Doesn't Dubya want to throw money at the problem?
Jim Chinnis - 30 Dec 2005 19:21 GMT
Jay Stallworth <jstall860@aol.com.nospam> wrote in part:
>Doesn't Dubya want to throw money at the problem?
He's already thrown it all away.
--
Jim Chinnis Warrenton, Virginia, USA
Jay Stallworth - 31 Dec 2005 20:32 GMT
> Jay Stallworth <jstall860@aol.com.nospam> wrote in part:
>
>>Doesn't Dubya want to throw money at the problem?
>
> He's already thrown it all away.
As the Deficit Spender in Chief, his financial resources are limitless.